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Abstract: The increasing threat of Acinetobacter baumannii as a nosocomial pathogen is mainly
due to the occurrence of multidrug-resistant strains that are associated with the real problem
of its eradication from hospital wards. The particular ability of this pathogen to form biofilms
contributes to its persistence, increases antibiotic resistance, and promotes persistent/device-related
infections. We previously demonstrated that virstatin, which is a small organic compound known to
decrease virulence of Vibrio cholera via an inhibition of T4-pili expression, displayed very promising
activity to prevent A. baumannii biofilm development. Here, we examined the antibiofilm activity
of mono-unsaturated chain fatty acids, palmitoleic (PoA), and myristoleic (MoA) acids, presenting
similar action on V. cholerae virulence. We demonstrated that PoA and MoA (at 0.02 mg/mL) were
able to decrease A. baumannii ATCC 17978 biofilm formation up to 38% and 24%, respectively,
presented a biofilm dispersing effect and drastically reduced motility. We highlighted that these
fatty acids decreased the expression of the regulator abaR from the LuxIR-type quorum sensing (QS)
communication system AbaIR and consequently reduced the N-acyl-homoserine lactone production
(AHL). This effect can be countered by addition of exogenous AHLs. Besides, fatty acids may have
additional non-targeted effects, independent from QS. Atomic force microscopy experiments probed
indeed that PoA and MoA could also act on the initial adhesion process in modifying the material
interface properties. Evaluation of fatty acids effect on 22 clinical isolates showed a strain-dependent
antibiofilm activity, which was not correlated to hydrophobicity or pellicle formation ability of the
tested strains, and suggested a real diversity in cell-to-cell communication systems involved in
A. baumannii biofilm formation.
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1. Introduction
Acinetobacter baumannii is a bacterial pathogen causing nosocomial outbreaks worldwide and
is responsible for many infections, such as pneumonia and bloodstream infections, especially
in intensive cares units [1,2]. Due to its exceptional adaptability to detrimental environmental
conditions, this bacterial species has rapidly emerged as a Multi-Drug Resistant (MDR), but also
XDR (extensively-DR) and now, more and more often, as a PDR (Pan-DR) organism. This led the
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World Health Organization to classify A. baumannii among the “Critical” bacterial agents (priority 1),
for which research and development of new and effective antibiotic treatments are urgently required.
Besides, this pathogen is also problematic for its long-time survival in hospital settings owing to its
great ability to survive desiccation [3] or treatment with disinfectants [4]. This persistence is mostly
linked to its capacity to form biofilms [5,6]. Virstatin is known to inhibit expression of cholera toxin
(encoding by ctx genes) and toxin co-regulated pilus (a type IV pilus, T4P, encoding by tcp genes),
two major virulence factors of Vibrio cholerae. We previously demonstrated that this small organic
molecule prevents A. baumannii biofilm production possibly via inhibition of pili biosynthesis [7–9].
Virstatin antibiofilm activity was recently confirmed on Acinetobacter nosocomialis [10], and could be due
to an inhibition of the Quorum-sensing (QS) system. QS is a communication system that orchestrates
bacterial behaviors within a microenvironment to promote community establishment by the regulation
of specific genes. In most gram-negative bacteria, signal molecules, called acyl-homoserine lactones
(AHLs), are diffusible autoinducers that are characterized by a length variable acyl-chain coupled with a
homoserine lactone ring [11]. In A. baumannii, different type of AHLs have been described [12], the most
commonly described ones are long chain AHLs with C10 or C12 acyl chains [13–15]. When considering
its crucial involvement in biofilm development, QS is an interesting target for the development of
antibiofilm strategies that can act either by inhibiting the signal molecule synthesis, or by degrading or
quenching this signal in the external environment [12]. Some mono-unsaturated fatty acids (UFAs) as
palmitoleic (cis-9-hexadecenoïc, C16:1∆9, PoA) and myristoleic (cis-9-tetradecenoïc, C14:1∆9, MoA)
acids were shown to inhibit tcp genes expression in V. cholerae [16,17]. These molecules prevent the
interaction between their transcriptional regulator ToxT and the DNA [18]. Bactericidal activity of
UFAs, in particular against cutaneous pathogens, has already been described [19–21]. Besides, UFAs
can also affect virulence factor expression, initial adhesion, or motility [20]. In this study, we evaluated
the efficacy of unsaturated fatty acids, PoA and MoA, as antibiofilm compounds and investigated their
effect on A. baumannii QS system.
2. Results and Discussion
2.1. Effect of UFAs on A. baumannii ATCC 17978 Biofilm Growth and Motility
Activity of PoA and MoA was preliminary tested on A. baumannii ATCC 17978 reference strain
forming both a biofilm at the solid-liquid interface and a pellicle. In the planktonic growth mode, MICs
of 4 mg/mL were obtained for each UFA. To investigate the antibiofilm activity of these compounds,
we used sub-inhibitory concentrations at least 100-fold lower than the MICs, i.e., 0.01, 0.02 and 0.05
mg/mL, concentrations in agreement with those used to decrease production of T4P in V. cholerae [17].
At these concentrations, fatty acids did not modify bacterial growth (Figure S1). The biofilm formation
inhibition by fatty acids is clearly depicted by the Figure 1a. Addition of PoA reduced significantly
the biofilm formation at the three tested concentrations (up to 37% and 39% reduction at 0.02 and
0.05 mg/mL, respectively), whereas MoA exhibited a significant activity only at 0.02 and 0.05 mg/mL
(decrease of 28% and 42% respectively). These results showed that UFAs display a biofilm inhibition
activity that is similar to that of virstatin, for which the decrease reached 32%, MoA being however
less active than PoA at lower concentrations. Biofilm dispersion activity of UFAs was investigated
on 24 h-static biofilms. Incubation of biofilms with MoA or PoA for anadditional 24 h demonstrated
that these UFA displayed significant dispersive activity as compared to virstatin (decrease of 24%
for MoA and PoA at 0.05 mg/mL, Figure 1a). Finally, A. baumannii surface motility was tested on
semi-solid medium plate (0.3% agar) with or without UFAs (Figure 1b at 0.02 mg/mL and Table S1).
PoA impeded motility when added at 0.02 and 0.05 mg/mL and MoA also significantly decreased the
motility up to 73% at 0.05 mg/mL.
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Figure 1. UFAs activity on A. baumannii ATCC 17978 motility and biofilm formation. (a) Inhibition and
dispersion of biofilms quantified by crystal violet staining method. 24 h-biofilms were treated with or
without virstatin (100 µM), palmitoleic acid (PoA) or myristoleic acid (MoA) at different concentrations
(0.01 (UFA-1), 0.02 (UFA-2) or 0.05 (UFA-5) mg/mL) and DMSO as control; (b) Activity on motility.
Blue arrows measure the diameter of surface motility. Results are presented as (mean ± standard error
of mean). “***” for p < 0.0001, “**” for p < 0.01, “*” for p < 0.05 and “NS” for non-significant difference.
These results showed that UFAs prevent significantly motility and biofilm formation on
A. baumannii ATCC 17978 at sub-inhibitory concentrations (0.01, 0.02 and 0.05 mg/mL) with a better
activity of PoA (C16:1∆9) than MoA (C14:1∆9). This is in agreement with the observation that,
in V. cholera, UFAs activity, reducing the tcp gene expression, was improved by an increase of the length
chain and was also related to the presence of unsaturated bond and to the conformation (cis/trans) of
the molecule [16,17]. Moreover, unlike virstatin, PoA and MoA were shown to significantly disperse
24 h-biofilms. Some Gram-bacteria produced cis-UFAs, also called Diffusible Signaling Factors (DSF).
These QS signals have been shown to be involved in cell-to-cell communication and could regulate
biofilm lifestyle [22]. For example, the UFA cis-2-decenoic acid (CDA) from the DSF family was shown
to be an autoinducer of the biofilm dispersion in P. aeruginosa and in many others species [23–26].
PoA and MoA might possess similar activity in A. baumannii biofilms. It was already shown that the
addition of an exogenous DSF, i.e., cis-2-dodecenoic (BDSF), inhibits P. aeruginosa biofilm formation by
interfering with the production of AHL [27]. This prompted us to further examine the impact of UFAs
on A. baumannii QS.
2.2. Impact of UFAs on Quorum Sensing
It was previously shown that virstatin could interfere with QS system of A. nosocomialis,
by decreasing the expression of the anoR regulator of the LuxI/R-type AnoIR system [10]. This decrease
of anoR expression, in reducing the activation of anoI, gene that codes for the autoinducer synthase,
could decrease AHLs production. In order to determine if virstatin or UFAs could also impact the QS
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system in A. baumannii ATCC 17978, we examined the expression of the regulator abaR gene of the
AbaIR system (homologue of the anoR gene in A. nosocomialis). We found that virstatin, MoA or PoA
significantly decreased abaR expression suggesting these UFAs can interfere with the AbaIR QS system
of A. baumannii (Figure 2a and Table S1).
Figure 2. UFAs activity on A. baumannii ATCC 17978 quorum sensing system. (a) abaR gene expression
quantified by real time PCR of the total RNA isolated from bacteria grown in the presence of virstatin
(100 µM, Vir-100), PoA or MoA at 0.02 mg/mL (PoA-2 and MoA-2) relative to that of the bacteria
grown in DMSO alone; (b) UFAs activity on biofilm formation in presence of AHLs (500 nM) quantified
by crystal violet staining method. 24 h-biofilm formation with or without virstatin (100 µM), PoA or
MoA at 0.02 mg/mL and DMSO as control. Results are presented as (mean ± standard error of mean).
“***” for p < 0.0001, “**” for p < 0.01 and “NS” for non-significant difference.
To confirm the impact of these compounds on the production of AHLs, we first performed
cross-streaking of A. tumefaciens and C. violaceum biosensors against A. baumannii ATCC 17978 to
determine the type of AHLs, i.e., short or/and long-type, which are produced by this strain [28].
In agreement with previous studies [13,14], we only detected the production of long-AHLs by
A. baumannii ATCC 17978 (Figure S2). To further examine the activity of UFAs and virstatin on
AHLs production, we evaluated the activity of these compounds on the A. baumannii biofilm formation
in presence of 500 nM of the main AHLs already described, i.e., OH-C12-HSL or N-C10-HSL [13–15]
(Figure 2b). If OH-C12-HSL addition completely restored the biofilm formation when A. baumannii was
treated by MoA, it only partially counteracted the activity of virstatin and PoA (recovery of 54 and
38% of the phenotype, respectively). The addition of N-C10-HSL also totally inhibited the effect of
MoA as well as the effect of virstatin (98% and 100% of recovery, respectively), whereas no significant
activity of N-C10-HSL was shown on biofilms treated with PoA (only 4% of recovery, Figure 2b).
Addition of AHLs on motility plates did not restore the motility of A. baumannii ATCC 17978 abolished
by virstatin or UFAs. Finally, we tested virstatin and UFAs via the QS screening platform developed
by Skogman et al. [29]. Neither virstatin nor UFAs (up to 400 µM) could be characterized as quorum
quencher or quorum inhibitor of short AHLs production.
In line with the previous data obtained on A. nosocomialis [10], these overall results indicate that
virstatin, but also UFAs, could prevent biofilm formation via an inhibition of abaR gene expression.
The consequent abaI autoinducer synthase gene repression could thus lead to an inhibition of the
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long-AHLs production. It has been shown that a deletion of the abaI in A. baumannii M2 displayed a
40% reduction of biofilm formation [13], a decrease that is similar to the one induced by virstatin or
UFAs. For PoA, the partial recovery of biofilm formation after addition of C10- or C12-HSL suggests
that this UFA alters the AHLs production, but could also act on another QS communication system not
yet characterized.
2.3. UFAs Affect Biofilm Architecture
We next investigated pellicles formed by ATCC 17978 after treatment with either virstatin or
UFAs. The pellicle formed by the ATCC 17978 strain showed aggregates on the air-facing side
(the “ball-shaped” morphogroup according to [30]) in control growth or in the presence of virstatin.
After 24 h of UFA treatment, these aggregates disappeared (Figure 3a). Pellicles were further
characterized by AFM. After 6 h of growth, control and virstatin-treated pellicles exhibited a similar
macroscopic aspect with merging microcolonies characterized by a diameter of about 50–100 µm
and an average thickness of (360–460 ± 40) nm (Figure 3b). However, with UFAs, tridimensional
architecture was abolished, leading to a monolayer structure with an average thickness of (230 ± 40)
nm and (150± 40) nm with PoA and MoA, respectively. This monolayer cellular organization appeared
to be less cohesive after PoA treatment than after the MoA one. We also observed elongated cells inside
the pellicle formed with and without UFAs (up to 20 µm of length versus 1 µm average for normal
cells, Figure 3b). When these elongated cells were inside the biofilm, they exhibited the same thickness
than normal cells (black circles in Figure 3b). However, in the presence of PoA or MoA, a large part of
these atypical cells seem to be lysed and their membranes expelled from the community (white arrows
in Figure 3b). UFC counts in the biofilms after 24 h with or without the presence of UFAs or virstatin
were similar (Figure S1).
Figure 3. UFAs activity on air-liquid biofilm organization. Pellicles were observed after growth with
or without virstatin, PoA or MoA. (a) Visual aspect of pellicle surface after 24 h treatment (b) Atomic
Force Microscopy (AFM) images of pellicle water-facing sides after 6 h treatment. From left side to
right side: DMSO control, pellicle formation with 100 µM virstatin, with 0.02 mg/mL MoA and with
0.02 mg/mL PoA. Elongated cells with a normal thickness are black encircled and lysed elongated cells
are pointed out with white arrows.
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These observations suggest a specific action of UFAs during the initial steps of biofilm formation,
i.e., on the cell adhesion. Indeed, due to their amphiphilic nature, UFAs go spontaneously at
the air-liquid interface where they could locally accumulate and lead to a first antibiofilm action.
In agreement with this hypothesis, it was previously shown that oleic acid (C18:1∆9, OA) inhibited the
primary adhesion step of S. aureus on polystyrene surfaces [31]. We also observed that the addition
of UFAs in MH medium significantly reduced the air/liquid surface tension. It has been already
demonstrated that this type of interface alteration, due to addition of biosurfactants, for an example,
significantly reduced pellicle formation or induced biofilm dispersion [32,33]. Finally, the observation
of the air-liquid interface by Brewster Angle Microscopy [30] demonstrates that if DMSO did not
influence the organization of the monolayer formed by the growth medium molecules, in the presence
of UFAs, the fluidity of this monolayer drastically increased. The influence of this parameter on the
pellicle formation is difficult to evaluate, but one might suggest that the irreversible adhesion step,
preluding microcolony formation during biofilm development, might be more difficult to achieve for
bacteria on fluid surface. Taken together, these overall results suggest that, besides its action on QS
system, the antibiofilm activity of UFAs could also be due, at least in initial steps of biofilm formation,
to several modifications of the interfaces on which the biofilm settles.
2.4. UFAs Effect on Biofilm Formation and Mobility of Clinical Isolates
To evaluate more broadly the UFAs activity on A. baumannii biofilms, we tested MoA and PoA
on 22 clinic isolates from different origins [34]. We quantified the biofilm formation of these strains
grown with or without UFAs at 0.02 mg/mL. PoA decreased significantly the biofilm formation in
13 of strains with a maximum reduction of 44% (Figure S3). With MoA, eight strains exhibited a
significant reduction of their biofilm formation ability. As observed with the ATCC 17978 strain, PoA
displayed a better antibiofilm activity than MoA, but no relationship between the antibiofilm activity
of virstatin and the one of UFAs could be emphasized [7]. UFAs antibiofilm activity seems not to be
correlated to the pellicle formation ability or hydrophobicity of the strain (Figure S3). For some strains,
UFAs addition slightly promoted the biofilm formation. Cross-streaking of A. tumefaciens biosensor
against these isolates confirmed the efficiency of the AHL QS system by long AHL production.
Several hypotheses can be proposed to explain this increase. In S. aureus, it was shown that OA
could promote biofilm formation, probably by interaction between positive charges of adhesion
factors and negative charges of UFAs [31,35]. Expression of adhesion factors in A. baumannii was
shown to be strain-dependent [36] and might explain this increasing effect. One can notice also
that the quorum quencher enzyme MomL displayed on A. baumannii biofilms a similar activity
as UFAs, with a maximum 42% decrease of the biomass formation and a strain-dependence of its
activity [37], suggesting that other cell-to-cell communication systems or factors could be recruited
during A. baumannii biofilm formation. In V. cholerae, UFAs (PoA and OA) were shown to interact and
prevent the DNA interaction of the AraC-type regulator, ToxT [17]. Additional interaction of UFAs with
such regulators in clinical isolates may also explain an increased biofilm formation. This demonstrates
that the UFAs activity is not limited to an activity an abaR gene.
3. Materials and Methods
3.1. Bacterial Strains and MICs Determination
To evaluate fatty acid activity, we used two reference strains of A. baumannii (i.e., ATCC
17978 and ATCC 19606) and a panel of 22 A. baumannii clinical isolates previously described [7,34].
Fatty acids, cis-9-hexadecenoic acid (C16:1∆9, palmitoleic acid, PoA, Sigma Aldrich, Lyon, France)
and cis-9-tetradecenoic acid (C14:1∆9, myristoleic acid, MoA, Sigma Aldrich, France) and virstatin
(4-[N-(1,8-naphthalimide)]-n-butyric acid, Bachem, Bubendorf, Germany) were solubilized in dimethyl
sulfoxide (DMSO, Sigma, St. Louis, MO, USA). Determination of UFAs minimal inhibitory
concentrations (MIC) were performed by the microdilution method, as previously described by [7].
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3.2. UFAs Activities on Biofilm Formation and Motility of A. baumannii Strains
A. baumannii biofilms were grown on 24-well plates in Mueller Hinton broth (MHB, Difco, Sparks,
NV, USA) at 37 ◦C as previously described [7]. To test their inhibition activity on A. baumannii biofilms,
fatty acids were introduced at final concentration of 0.02 mg/mL (as well as 0.01 and 0.05 mg/mL for
ATCC 17978 strain), using DMSO as negative control and 100 µM virstatin as positive control [7,17].
In case of strains forming pellicle in addition to biofilms on plate walls, the sub-phase was gently
removed allowing the pellicle to stick onto the plate walls, then the overall remaining biomass
(i.e., biofilm on solid surface and pellicle) was quantified, as described by [38]. Biofilm dispersion
activity of UFAs was investigated only on 24 h-biofilms formed by ATCC 17978 strain in MHB.
Twenty four-hour biofilms were incubated in fresh medium for an additional 24 h in the presence of
fatty acids (at 0.01, 0.02, or 0.05 mg/mL) using DMSO or virstatin 100 µM as controls. Surface motility of
A. baumannii strains was investigated in 0.3% Luria Bertani agar (LB; Difco) Petri dishes supplemented
or not with UFAs and DMSO as control and incubated overnight at 37 ◦C [39]. All of the experiments
were performed at least in triplicate. Data were statically analyzed using Prism Graph Pad 5 with a
t-test to determine a significant effect of UFAs.
3.3. Effect of Virstatin and UFAs on Quorum Sensing
The N-acyl-homoserine lactone (AHL) production in A. baumannii ATCC 17978 or A. baumannii
clinical isolates was determined, as described by [28] with P. aeruginosa PAO1 and E. coli ATCC 10536
as positive and negative controls, respectively. To investigate the potential quorum-quenching activity
of UFAs and virstatin on short-HSLs, we used the screening platform described by [29]. The effect
of the addition of long-HSLs, i.e., N-(3-hydroxydodecanoyl)-DL-homoserine lactone (OH-C12-HSL,
Sigma Aldrich) and N-decanoyl-DL-homoserine lactone (N-C10-HSL, Sigma Aldrich) solubilized in
DMSO, on biofilms pretreated by virstatin and UFAs was investigated. Five hundred nM of each
HSL were added concomitantly to 0.02 mg/mL of UFAs and 100 µM virstatin. DMSO enriched with
HSL (500 nM) was used as control. Biofilm formation was quantified and the results significance was
analyzed, as described in the previous section. The effect of virstatin and UFAs on abaR gene expression
using q-RT-PCR was also investigated. A. baumannii was grown overnight in MH medium and diluted
to OD600 of 0.01 and incubated for 24 h under agitation at 37 ◦C with DMSO (negative control), virstatin
(100 µM), MoA (0.02 mg/mL), or PoA (0.02 mg/mL). Total RNAs were extracted using RNeasy-Mini
kit (Qiagen, Valencia, CA, USA), followed by a supplementary DNase treatment (Ambion, Carlsbad,
CA, USA), and a verification of absence of contaminating DNA by PCR. RNAs were reverse-transcribed
using QuantiTect Reverse Transcription Kit (Qiagen). Real-time PCR was performed using Brilliant
III SYBR Green QPCR (Agilent Technologies, Santa Clara, CA, USA) with an AriaMx Real-Time PCR
System (Agilent Technologies). Specific primers are listed in Table S1. The rpoB expression was used
as an internal control for normalization and fold change calculated in relation to the DMSO control.
Data were analyzed using Prism Graph Pad 5 with a one-way ANOVA (n = 4).
3.4. Impact of UFAs on A. baumannii Biofilm Morphology
Morphological changes of liquid-facing sides of A. baumannii ATCC 17978 pellicles were visualized
by Atomic Force Microscopy (AFM) after 6h of growth with or without 0.02 mg/mL of UFAs or
100 µM virstatin, DMSO being used as control [7]. Modifications of air-water interfaces in presence of
UFAs and virstatin, were determined either by Brewster’s angle microscopy [30] or by surface tension
measurements using a Wilhelmy pressure sensor with a filter paper plate (R & K, Wiesbaden, Germany).
4. Conclusions
Involved in device-related infections and in persistence in hospital settings, the biofilm formation
is a major cause of concern in the battle against A. baumannii and deserves the research of new
therapeutic compounds. In this context, we previously demonstrated that virstatin, a factor decreasing
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T4P-pili expression in V. cholera [17], inhibits A. baumannii biofilm formation [7]. In this study,
we demonstrated that MoA and PoA also decreasing T4P-pili expression in V. cholera [16,17], inhibit
the biofilm formation and motility in A. baumannii. By decreasing the expression of the QS system
regulator, abaR, these three compounds inhibit AHLs production that could be restored by AHL
exogenous addition. However, UFAs, as hydrophobic compounds, also modify material interfaces, as
shown here by the modification of the air-liquid interface, precluding initial steps of biofilm formation.
Additional bacterial responses that are uncorrelated to QS communication system or sensing of
surfaces might also be induced by the use of these compounds, like overexpression of genes involved
in stress response, or the regulation of peptidoglycan biosynthesis highlighted in S. aureus under OA
treatment [40], and merit further investigation.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/19/1/214/s1.
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Abbreviations
AFM Atomic force microscopy
AHL N-acyl-homoserine lactone
ATCC American type culture collection
DMSO Dimethyl sulfoxide
HSL Homoserine lactone
MIC Minimal inhibitory concentration
MoA Myristoleic acid
PoA Palmitoleic acid
OA Oleic acid
PCR Polymerase chain reaction
QS Quorum sensing
UFA Unsaturated fatty acid
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